Drug Shortage Report for HP-PAC

Last updated on 2020-03-26 History
Report ID 104791
Drug Identification Number 02238525
Brand name HP-PAC
Common or Proper name AMOXICILLIN, LANSOPRAZOLE, CLARITHROMYCIN
Company Name TAKEDA PHARMACEUTICALS AMERICA INC
Market Status MARKETED
Active Ingredient(s) AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN
Strength(s) 500MG 30MG 500MG
Dosage form(s) KIT CAPSULE TABLET CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size HP PAC 7DAY THERAPY
ATC code A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-24
Estimated end date Unknown
Actual end date 2020-03-25
Shortage status Resolved
Updated date 2020-03-26
Company comments product to be discontinued
Health Canada comments
Contact Address 95 HAYDEN AVENUE
LEXINGTON, MASSACHUSETTS
UNITED STATES 02421
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-03-26 English Compare
v4 2020-03-25 French Compare
v3 2020-03-25 English Compare
v2 2020-01-30 French Compare
v1 2020-01-30 English Compare